We support psychedelic drug development trials with experienced teams who understand CNS indications and evolving regulations.
Our services include protocol design, site qualification, rater training, and placebo response mitigation - specific challenges in psychedelic research.
Whether you're studying mood disorders, PTSD, anxiety, or OCD, we help ensure reliable endpoint data through each trial phase.
